[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]
- PMID: 18167265
[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]
Abstract
Objective: To investigate the antimicrobial resistance among the nosocomial gram-negative pathogens from 15 teaching hospitals located in different areas in China in 2005.
Methods: A total of 1927 non-repetitive nosocomial gram-negative pathogens were collected from 15 teaching hospitals in different areas in China and sent to the central lab for reidentification and susceptibility testing. The levels of minimal inhibitory concentration (MIC) of 18 antimicrobial agents were determined by agar dilution method. WHONET 5.4 software was used to analyze the data.
Results: The strains of Escherichia coli, Klebsiella pneumoniae, and Proteous mirabilis isolates that did not produce extended spectrum beta lactamases (ESBLs) showed high sensitivity to beta-lactams. The antibiotics with a susceptibility rates over 80% against the strains of Entorobacter cloacae, Enterobacter aerogene, Citrobacter spp, Serratia spp, and Proteous vulgaris producing AmpC enzyme included meropenem, imipenem, and piperacillin-tazobactam, and these 3 drugs showed a susceptibility rate of more than 80% against the ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae. Other antimicrobial agents showing a relatively high activity against Enterobacter spp, Citrobacter spp, Serratia spp and Proteous vulgaris included cefepime (67.3% - 100%), amikacin (67.3% - 95.2%), ceftazidime (52.9% - 100%) and cefoperazone-sulbactam (51.9% - 100%). The susceptibility rate of fluoroquinolones was 34.8% - 36.1% against non-ESBL-producing Escherichia coli and was 13.4% - 17.1% against ESBL-producing isolates. The most active agent against Pseudomonas aeruginosa was polymyxin B (95.6%). The agents with the activity rates of 70% - 80% included meropenem, imipenem, amikacin, and piperacillin-tazobactam. The antibiotic with a high susceptible rate against Acinetobacter baumannii was polymyxin B (98.3%), followed by imipenem (80.8%), meropenem (76.2%), and minocycline (67.4%). The susceptible rates of other agents were all below 60%. The agents with relatively high activity against Stenotrophomonas maltophilia included minocycline (85%), levofloxacin (82.5%), and trimethoprim-sulfamethoxazole (77.5%). The agents with a relatively high activity against Burkholderia cepacia included minocycline (77.2%) and meropenem (61.4%).
Conclusion: Carbapenem, piperacillin-tazobactam, amikacin and cefepime remained relatively high activity against nosocomial Enterobacteriaceae, Non-fermenting pathogens have lower susceptibility to the antimicrobial agents than before.
Similar articles
-
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12820912 Chinese.
-
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):385-90. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12820914 Chinese.
-
[Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].Zhonghua Yi Xue Za Zhi. 2013 May 14;93(18):1388-96. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24025503 Chinese.
-
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.Int J Antimicrob Agents. 2005 Feb;25(2):95-109. doi: 10.1016/j.ijantimicag.2004.10.002. Int J Antimicrob Agents. 2005. PMID: 15664479 Review.
-
Tigecycline: in-vitro performance as a predictor of clinical efficacy.Clin Microbiol Infect. 2007 Apr;13(4):354-62. doi: 10.1111/j.1469-0691.2006.01621.x. Clin Microbiol Infect. 2007. PMID: 17359318 Review.
Cited by
-
Antibiotic resistance amongst healthcare-associated pathogens in China.Int J Antimicrob Agents. 2012 Nov;40(5):389-97. doi: 10.1016/j.ijantimicag.2012.07.009. Epub 2012 Sep 20. Int J Antimicrob Agents. 2012. PMID: 22999767 Free PMC article. Review.
-
Polymyxin B resistance rates in carbapenem-resistant Pseudomonas aeruginosa isolates and a comparison between Etest® and broth microdilution methods of antimicrobial susceptibility testing.Exp Ther Med. 2020 Aug;20(2):762-769. doi: 10.3892/etm.2020.8777. Epub 2020 May 20. Exp Ther Med. 2020. PMID: 32742322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous